Though it’s been linked tenuously in the past to psychological stressors and genetics, the majority of cases of spontaneous coronary artery dissection (SCAD) can’t be traced back to a concomitant arteriopathy, inflammatory disorder or evident risk factor, according to research published in the American Journal of Cardiology Oct. 29.

The expanded window for thrombectomy in acute stroke care ranked No. 3 on Cleveland Clinic’s top 10 medical innovations for 2019—one of several developments on the list with implications for cardiovascular treatment.

Cardiac transplant candidates are better off accepting an organ with a higher risk of transmitting diseases than waiting for another heart, suggests a study published Oct. 29 in the Journal of the American College of Cardiology.

A therapeutic vaccine developed in Japan could work as well as oral antithrombotic drugs to prevent secondary ischemic stroke, according to preliminary research published Oct. 29 in Hypertension.

Researchers from Northwestern University developed an easy-to-calculate, four-factor score which identified 92.2 percent of true strokes among 330 inpatients who triggered stroke alerts.

Evolocumab appears to be equally effective at reducing LDL cholesterol and preventing cardiovascular events regardless of a patient’s kidney function, according to a new subanalysis of the FOURIER outcomes study presented at the American Society of Nephrology’s annual Kidney Week in San Diego.

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

Omega-3 treatment was associated with significantly fewer gastrointestinal bleeding events for patients with left ventricular assist devices (LVADs), researchers reported in Circulation: Heart Failure.